Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis

Completed · Not applicable

Conditions studied: Systemic Sclerosis, SSc

In brief

The purpose of this study is to test two rehabilitation programs to improve arm function for patients with scleroderma. This is a Phase 2 randomized controlled trial in which participants will be assessed at baseline, 8 weeks, and 18 weeks. Participants will be randomized into an intensive intervention (8 individual sessions of occupational therapy plus a home exercise app) versus a home app treatment alone. The results of this study will be used to design a large multi-site trial in which optimized rehabilitation strategies can be used to help patients improve their arm function.

Key facts

Study ID

NCT03482219

Run by

University of Michigan

People needed

32

Starts

2018-04-16

Expected to finish

2020-09-26

Last updated by the study team

2020-09-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a diagnosis of systemic sclerosis including:
• Diffuse cutaneous subset
• Disease duration < 5 years from 1st non Raynaud phenomenon sign or symptom
• Have a contracture of the hand and other joint in at least one arm, such as wrist, elbow, or shoulder, with the ability to demonstrate active range of motion in that arm
• Willing to travel to participate in therapy and outcome assessments.
• Have an Android, iPhone, iPad or computer tablet to load the home exercise App.
• English speaking

You may not qualify if…

• issues that preclude meaningful participation in study procedures (e.g. concurrent or complex medical issues, inability to use home exercise app, etc.)

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.